Literature DB >> 30460626

Quantification of [18F]UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value.

Maria Elisa Serrano1, Mohamed Ali Bahri2, Guillaume Becker2, Alain Seret2, Frédéric Mievis3, Fabrice Giacomelli3, Christian Lemaire2, Eric Salmon2, André Luxen2, Alain Plenevaux2.   

Abstract

PURPOSE: [18F]UCB-H is a specific positron emission tomography (PET) biomarker for the Synaptic Vesicle protein 2A (SV2A), the binding site of the antiepileptic drug levetiracetam. With a view to optimising acquisition time and simplifying data analysis with this radiotracer, we compared two parameters: the distribution volume (Vt) obtained from Logan graphical analysis using a Population-Based Input Function, and the Standardised Uptake Value (SUV). PROCEDURES: Twelve Sprague Dawley male rats, pre-treated with three different doses of levetiracetam were employed to develop the methodology. Three additional kainic acid (KA) treated rats (temporal lobe epilepsy model) were also used to test the procedure. Image analyses focused on: (i) length of the dynamic acquisition (90 versus 60 min); (ii) correlations between Vt and SUV over 20-min consecutive time-frames; (iii) and (iv) evaluation of differences between groups using the Vt and the SUV; and (v) preliminary evaluation of the methodology in the KA epilepsy model.
RESULTS: A large correlation between the Vt issued from 60 to 90-min acquisitions was observed. Further analyses highlighted a large correlation (r > 0.8) between the Vt and the SUV. Equivalent differences between groups were detected for both parameters, especially in the 20-40 and 40-60-min time-frames. The same results were also obtained with the epilepsy model.
CONCLUSIONS: Our results enable the acquisition setting to be changed from a 90-min dynamic to a 20-min static PET acquisition. According to a better image quality, the 20-40-min time-frame appears optimal. Due to its equivalence to the Vt, the SUV parameter can be considered in order to quantify [18F]UCB-H uptake in the rat brain. This work, therefore, establishes a starting point for the simplification of SV2A in vivo quantification with [18F]UCB-H, and represents a step forward to the clinical application of this PET radiotracer.

Entities:  

Keywords:  Distribution volume; KASE; PET; Quantification; SUV; SV2A; [18F]UCB-H

Mesh:

Substances:

Year:  2019        PMID: 30460626     DOI: 10.1007/s11307-018-1301-0

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  45 in total

Review 1.  Quantification in PET.

Authors:  Paul D Acton; Hongming Zhuang; Abass Alavi
Journal:  Radiol Clin North Am       Date:  2004-11       Impact factor: 2.303

Review 2.  Image-derived input function for brain PET studies: many challenges and few opportunities.

Authors:  Paolo Zanotti-Fregonara; Kewei Chen; Jeih-San Liow; Masahiro Fujita; Robert B Innis
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-03       Impact factor: 6.200

Review 3.  Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.

Authors:  Giampaolo Tomasi; Federico Turkheimer; Eric Aboagye
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

Review 4.  Quantitative positron emission tomography in brain research.

Authors:  Kerstin Heurling; Antoine Leuzy; My Jonasson; Andreas Frick; Eduardo R Zimmer; Agneta Nordberg; Mark Lubberink
Journal:  Brain Res       Date:  2017-06-23       Impact factor: 3.252

Review 5.  Kinetic modeling in PET imaging of hypoxia.

Authors:  Fan Li; Jesper T Joergensen; Anders E Hansen; Andreas Kjaer
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

6.  Modification of seizure activity by electrical stimulation. II. Motor seizure.

Authors:  R J Racine
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-03

7.  Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.

Authors:  Jean-Marie Nicolas; Jonas Hannestad; Daniel Holden; Sophie Kervyn; Nabeel Nabulsi; Dominique Tytgat; Yiyun Huang; Hugues Chanteux; Ludovicus Staelens; Alain Matagne; François-Xavier Mathy; Joël Mercier; Armel Stockis; Richard E Carson; Henrik Klitgaard
Journal:  Epilepsia       Date:  2015-12-10       Impact factor: 5.864

8.  Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H.

Authors:  Mohamed Ali Bahri; Alain Plenevaux; Joël Aerts; Christine Bastin; Guillaume Becker; Joël Mercier; Anne Valade; Tim Buchanan; Nathalie Mestdagh; Didier Ledoux; Alain Seret; André Luxen; Eric Salmon
Journal:  Alzheimers Dement (N Y)       Date:  2017-08-30

Review 9.  Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients.

Authors:  Antonia Dimitrakopoulou-Strauss; Leyun Pan; Ludwig G Strauss
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

10.  Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H.

Authors:  Florian Bretin; Geoffrey Warnock; Mohamed Ali Bahri; Joël Aerts; Nathalie Mestdagh; Tim Buchanan; Anne Valade; Frédéric Mievis; Fabrice Giacomelli; Christian Lemaire; André Luxen; Eric Salmon; Alain Seret; Alain Plenevaux
Journal:  EJNMMI Res       Date:  2013-05-07       Impact factor: 3.138

View more
  5 in total

Review 1.  Synaptic Vesicle Glycoprotein 2A: Features and Functions.

Authors:  Rachele Rossi; Shokouh Arjmand; Simone Larsen Bærentzen; Albert Gjedde; Anne M Landau
Journal:  Front Neurosci       Date:  2022-04-28       Impact factor: 5.152

Review 2.  The Rise of Synaptic Density PET Imaging.

Authors:  Guillaume Becker; Sylvestre Dammicco; Mohamed Ali Bahri; Eric Salmon
Journal:  Molecules       Date:  2020-05-14       Impact factor: 4.411

Review 3.  Imaging Synaptic Density: The Next Holy Grail of Neuroscience?

Authors:  Maria Elisa Serrano; Eugene Kim; Marija M Petrinovic; Federico Turkheimer; Diana Cash
Journal:  Front Neurosci       Date:  2022-03-25       Impact factor: 4.677

4.  Longitudinal [18]UCB-H/[18F]FDG imaging depicts complex patterns of structural and functional neuroplasticity following bilateral vestibular loss in the rat.

Authors:  Melissa Antons; Magdalena Lindner; Maximilian Grosch; Rosel Oos; Giovanna Palumbo; Matthias Brendel; Sibylle Ziegler; Peter Bartenstein; Marianne Dieterich; Andreas Zwergal
Journal:  Sci Rep       Date:  2022-04-11       Impact factor: 4.379

5.  Evaluating the In Vivo Specificity of [18F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET.

Authors:  Maria Elisa Serrano; Guillaume Becker; Mohamed Ali Bahri; Alain Seret; Nathalie Mestdagh; Joël Mercier; Frédéric Mievis; Fabrice Giacomelli; Christian Lemaire; Eric Salmon; André Luxen; Alain Plenevaux
Journal:  Molecules       Date:  2019-05-01       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.